Market Analysis

Infectious Diseases Therapeutic Market
The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious Diseases Diagnostics Market Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

Worldwide deaths due to Infectious Diseases

Current Outbreak
The deadliest Ebola outbreak in recorded history is happening right now. The outbreak is unprecedented both in the number of cases and in its geographic scope. And so far, it doesn't look like it's slowing down. The outbreak has now hit three countries: Guinea, Sierra Leone, and Liberia. And the virus — which starts off with flu-like symptoms and often ends with horrific hemorrhaging — has infected about 600 people and killed an estimated 367 since this winter, according to the numbers on June 26 from the World Health Organization.

Recent Outbreak (Zika virus): Zika virus is the current outbreak occurring from in many countries. It is affected to people primarily through the bite of an infected Aedes species mosquito (Ae. aegypti and Ae. albopictus). Zika can also be passed through sex from a person who has Zika to his or her sex partners and it can also spread by pregnant woman to her fetus. The National Institutes of Health, USA say trials for Zika vaccine is about to start in September this year. Depending on the results, larger trials could begin at the start of 2017. Up to date 2015-16 total 69 Zika Virus cases reported with 16 live born infants with birth defects and 5 total pregnancy losses with birth defects.

Members associated with Infectious Diseases

  • Centre for Infectious Diseases and Policy includes 218 members
  • Global Public Health is having 106913 members
  • Members Pediatric Infectious Disease and Immunology has 3291 members
  • European Society of Clinical Microbiology and Infectious Diseases has 3438 members
  • Infectious Diseases Society has 707 members
Worldwide Data
  • Worldwide members of Infectious are 3,683 members
  • European Congress in Clinical Microbiology and Infectious Diseases is having 1,369 members
  • National Foundation for Infectious Diseases has 365 members
  • UNC Institute for Global Health & Infectious Diseases has237 members
  • Cirion; bridging the gap in infectious diseases between science and society has55 members
  • HIV/AIDS & Infectious Diseases has 85 members
  • M.S. in Public Health Microbiology & Emerging Infectious Diseases has 44 members
  • Infectious Diseases and Public Health (IDPH) Research Group has 45 members
  • EUPHA Section Infectious diseases control has 38 members
  • Center for Structural Genomics of Infectious Diseases (CSGID) has30 members
  • LSHTM_Control of Infectious Diseases has 19 members
Societies and Associations related to Infectious Diseases
  • Healthcare Infection Society
  • European Society for Pediatric Infectious Diseases
  • European Society of Clinical Microbiology and Infectious Diseases
  • Infection Prevention Society
  • British Society for Immunology
  • British Infection Association
  • British Infection Association
  • European Society for pediatric Infectious diseases
  • Health care Infection Society
  • Worldwide societies for infectious diseases is about 150
Universities related to Infectious Diseases
  • University of Cambridge
  • Kings College of London
  • London School of Hygiene and Tropical Medicine
  • Imperial College London
  • UCL Institute of Epidemiology and Health care
  • University of Sheffeild
  • Pediatric Infectious Diseases Society
  • Columbia University
  • University of Maryland
  • Swedish Institute for Infectious Disease Control
  • Uppsala University
  • University of Gothenburg
  • University of Otago
  • Oslo University
  • University of Pittsburgh
  • Emory Health Sciences
  • Queensland University of Technology
  • University of Liverpool
  • University of Colorado Denver
  • Infectious Diseases Society of America
  • Medical College of Georgia at Georgia Regents University
Market Analysis of Companies

Funding towards Infectious Diseases

Funding towards Infectious Diseases